Pharmafile Logo
Pharmafocus logo
Advanced Search

Almirall, the first to assess wellbeing in a dermatology clinical study

April 12, 2023
Business Services

BARCELONA, Spain. April 12, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced the …

News
Press release

Liberal states begin stockpiling abortion medications following Texas court ruling

April 12, 2023
Medical Communications

Various liberal US states, including California and Massachusetts, have begun stockpiling abortion medications following a Texas judge Matthew Kacsmaryk’s attempt …

News
diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna announces mixed success clinical updates for mRNA pipeline

April 12, 2023
Research and Development

Biotechnology company Moderna has announced clinical updates detailing the expansion and advancement of its mRNA pipeline, which includes treatments for …

News
christina-victoria-craft-whsnkiwwpec-unsplash_4

ImaginAb signs new license and supply agreement with Leucid Bio for CD8 ImmunoPET technology

April 12, 2023
Sales and Marketing

Biotechnology company ImaginAb has announced that it has signed a new non-exclusive License and Supply Agreement (LSA) with Leucid Bio. …

News
carlos-muza-hpjsku2uysu-unsplash_1

Cognizant and Boehringer Ingelheim collaborate on integrated cloud platform to improve therapy development

April 12, 2023
Medical Communications

US-based Cognizant and biopharmaceutical company Boehringer Ingelheim have announced a partnership to collaborate on ensuring the quality, and increasing the …

News

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

April 11, 2023
Business Services

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science …

News
Press release
christina-victoria-craft-zhys6xn7sue-unsplash_5

Molecular Templates announces hold for phase 1 study

April 11, 2023
Research and Development

Molecular Templates has announced that the FDA has placed a partial hold on its phase 1 study for MT-0169 based …

News

FDA authorises marketing of MISHA Knee System for patients with knee osteoarthritis

April 11, 2023
Medical Communications

Medical device company, Moximed, has announced that the FDA granted marketing authorisation of its MISHA Knee System, an implantable shock …

News

Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD

April 11, 2023
Business Services

LONDON and RALEIGH, N.C., April 11, 2023 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage …

News
Press release

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

April 11, 2023
Business Services

Leiden, The Netherlands, April 11, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the first commercial …

News
Press release

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

April 6, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening …

News
Press release
christina-victoria-craft-whsnkiwwpec-unsplash_4

AstraZeneca’s Lynparza approved by NHS England

April 6, 2023
Medical Communications

NHS England has approved the use of AstraZeneca’s Lynparza (olaparib) for the treatment of patients with breast cancer and prostate …

News
chuttersnap-oijvdm3zx4i-unsplash

Synapse receives FDA approval for its NeuRx DPS to treat patients with stable SCI

April 6, 2023
Research and Development

Synapse Biomedical has announced that it has gained premarket approval (PMA) from the FDA for its NeuRxDiaphragm Pacing System (NeuRx …

News

Innova Care Concepts expand their support to the medical negligence sector with the acquisition of Nurture Group Ltd.

April 5, 2023
Business Services

Press Release, Wednesday 5th April 2023, London… As part of a long-term strategy to increase its home adaptation services across …

News
Press release

Ipsen’s response to NICE’s decision on Cabometyx® (cabozantinib) for previously treated differentiated thyroid cancer unsuitable for or refractory to radioactive iodine

April 5, 2023
Business Services

  SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health and Care Excellence (NICE) …

News
Press release

Syncona Appoints Roel Bulthuis as Managing Partner

April 5, 2023
Business Services

05 April 2023   Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life …

Appointment

First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study

April 5, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …

News
Press release

BenevolentAI announces top-line Phase IIa results for its topical pan-Trk inhibitor BEN-2293 (1%) in mild-to-moderate atopic dermatitis

April 5, 2023
Business Services

London, UK, 5 April 2023: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI) announces top-line results from its Phase IIa, …

News
Press release

AstraZeneca reports positive results of drug combination in late-stage ovarian cancer trial

April 5, 2023
Medical Communications

AstraZeneca has announced positive high-level results from an interim analysis of the DUO-O phase 3 trial assessing a combination of …

News
hal-gatewood-ipl3q-gegzy-unsplash_2

FDA requires prepaid mail-back envelopes for opioid analgesics

April 5, 2023
Medical Communications

The FDA has announced that it will require opioid analgesic manufacturers to provide prepaid mail-back envelopes in outpatient pharmacies and …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026